-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
- Enanta Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$22.7M, a 42% increase year-over-year.
- Enanta Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$115M, a 12.7% increase year-over-year.
- Enanta Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$134M, a 9.91% decline from 2022.
- Enanta Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$122M, a 54.1% decline from 2021.
- Enanta Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$79M, a 118% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)